In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3

Schmidt, Jana; Schmidt, Thorsten; Golla, Matthias; Lehmann, Lisa; Weber, Jonasz Jeremiasz; Huebener-Schmid, Jeannette; Riess, Olaf

dc.contributor.author	Schmidt, Jana
dc.contributor.author	Schmidt, Thorsten
dc.contributor.author	Golla, Matthias
dc.contributor.author	Lehmann, Lisa
dc.contributor.author	Weber, Jonasz Jeremiasz
dc.contributor.author	Hübener-Schmid, Jeannette
dc.contributor.author	Rieß, Olaf
dc.date.accessioned	2016-10-28T11:32:27Z
dc.date.available	2016-10-28T11:32:27Z
dc.date.issued	2016
dc.identifier.issn	1471-4159
dc.identifier.uri	http://hdl.handle.net/10900/72877
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/jnc.13606	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_00205
utue.publikation.seiten	150-162	de_DE
utue.personen.roh	Schmidt, Jana
utue.personen.roh	Schmidt, Thorsten
utue.personen.roh	Golla, Matthias
utue.personen.roh	Lehmann, Lisa
utue.personen.roh	Weber, Jonasz Jeremiasz
utue.personen.roh	Huebener-Schmid, Jeannette
utue.personen.roh	Riess, Olaf
dcterms.isPartOf.ZSTitelID	Journal of Neurochemistry	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	138	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE